Here is your complete, doctor-level study guide for Harrison's Section 7: Alterations in Renal and Urinary Tract Function (Chapters 54-58). Every concept is organized to read fast, understand deeply, and remember permanently.
🫘 Harrison's Section 7 - Alterations in Renal & Urinary Tract Function
Chapters 54-58 | Master Study Guide
CHAPTER 54 - AZOTEMIA AND URINARY ABNORMALITIES
The Big Picture in One Sentence
Azotemia = elevated BUN and creatinine = kidney isn't clearing waste; localize it as pre-renal, intrinsic renal, or post-renal - this single classification drives your entire management.
🧬 Kidney Function Basics - What You Must Know First
GFR (Glomerular Filtration Rate):
- Normal: ~120 mL/min/1.73m²
- Best clinical estimate: CKD-EPI equation (replaces old MDRD)
- Serum creatinine alone is an unreliable GFR marker - affected by muscle mass, diet, drugs
BUN (Blood Urea Nitrogen):
- Normal: 8-20 mg/dL
- Elevated by: protein intake, GI bleeding, catabolic states, steroids, dehydration
- Decreased by: liver failure, low protein diet, SIADH
BUN:Creatinine Ratio:
- Normal: 10-15:1
- >20:1 = pre-renal (urea reabsorbed with water in hypovolemia)
- <10:1 = intrinsic renal, rhabdomyolysis (creatinine disproportionately high), liver disease
🎯 The Azotemia Classification - MASTER THIS
AZOTEMIA
|
├── PRE-RENAL (reduced perfusion, kidneys intact)
| ↓
| Oliguria + concentrated urine + respond to fluids
|
├── INTRINSIC RENAL (kidney itself damaged)
| ↓
| Specific urine findings help localize injury
|
└── POST-RENAL (obstruction below kidneys)
↓
Anuria or alternating oliguria/polyuria
Pre-Renal Azotemia
Mechanism: Decreased effective arterial blood volume → reduced renal perfusion → kidney conserves Na+ and water → concentrated urine with low Na+
Causes:
- True volume depletion: vomiting, diarrhea, bleeding, burns, diuretics
- Low cardiac output: heart failure, cardiogenic shock
- Altered vascular resistance: sepsis (distributive shock)
- Selective afferent constriction: NSAIDs block prostaglandin-mediated afferent dilation (critical in heart failure, cirrhosis)
- Selective efferent dilation: ACE inhibitors / ARBs - reduce GFR by dropping efferent resistance
Urine Indices:
| Index | Pre-Renal | Intrinsic Renal (ATN) |
|---|
| Urine Na+ | <20 mEq/L | >40 mEq/L |
| FENa (fractional excretion of Na+) | <1% | >2% |
| Urine osmolality | >500 mOsm/kg | ~300 (isosthenuria) |
| BUN:Cr ratio | >20:1 | ~10-15:1 |
| Urine specific gravity | >1.020 | ~1.010 |
FENa formula: FENa = (Urine Na × Plasma Cr) / (Plasma Na × Urine Cr) × 100
FENa <1% but still ATN? Yes - in contrast nephropathy, myoglobinuria, early obstruction, hepatorenal syndrome. Use FEUrea instead (FEUrea <35% = pre-renal) when diuretics given.
Intrinsic Renal Azotemia - Localize by Nephron Segment
Glomerular Disease
- Hematuria + proteinuria + RBC casts = nephritic syndrome (glomerulonephritis)
- Massive proteinuria (>3.5 g/day) + edema + hypoalbuminemia = nephrotic syndrome
- Causes: IgA nephropathy, post-streptococcal GN, lupus nephritis, ANCA vasculitis
Tubular Disease (ATN - most common cause of AKI in hospital)
- Causes: ischemia (shock), nephrotoxins (aminoglycosides, contrast, cisplatin, myoglobin, hemoglobin)
- Urine findings: muddy brown granular casts (classic) + tubular epithelial cells
- Phases: oliguric (days-weeks) → polyuric (recovery) → complete recovery
- FENa >2%; isosthenuria
Interstitial Disease (Acute Interstitial Nephritis - AIN)
- Causes: drug hypersensitivity (NSAIDs, antibiotics - especially beta-lactams, rifampin, PPIs), infections
- Classic triad: fever + rash + eosinophilia (only in ~30% - do not rely on it)
- Urine: WBC casts + eosinophiluria (dipstick often negative for blood/protein)
- Biopsy confirms; Treatment: stop offending drug ± steroids
Vascular Disease
- Renal artery stenosis (bilateral - ACE inhibitor can precipitate AKI)
- Thrombotic microangiopathy (HUS, TTP - schistocytes + thrombocytopenia)
- Cholesterol emboli: livedo reticularis, eosinophilia, after vascular procedure
Post-Renal Azotemia
Mechanism: Obstruction anywhere from renal pelvis to urethra → back pressure → GFR falls
Causes:
- Prostate enlargement (BPH) - most common in elderly men
- Cervical/pelvic cancer - bilateral ureteric obstruction
- Kidney stones (usually requires bilateral or solitary kidney)
- Urethral stricture, neurogenic bladder
Key Features:
- Anuria (complete obstruction) or oliguria
- Palpable bladder (if bladder outlet obstruction)
- Post-obstructive diuresis after relief (watch for electrolyte losses!)
- Ultrasound: hydronephrosis (dilated collecting system)
Treatment: Relieve obstruction promptly (Foley catheter, nephrostomy, stenting) - reversible if caught early
Urinary Abnormalities - Approach
Proteinuria
| Type | Amount | Clinical Significance |
|---|
| Microalbuminuria | 30-300 mg/day | Early diabetic nephropathy, cardiovascular risk |
| Macroalbuminuria | >300 mg/day | Established nephropathy |
| Nephrotic range | >3.5 g/day | Full nephrotic syndrome |
Urine dipstick: Detects albumin only (misses Bence-Jones protein - light chains)
Spot urine protein:creatinine ratio: Numerically approximates 24-hr protein excretion (ratio of 3.5 = 3.5 g/day)
Causes of non-nephrotic proteinuria:
- Orthostatic (postural): protein only when upright, disappears when supine - benign in young
- Tubular: small proteins (beta-2 microglobulin, RBP) - from tubular injury
- Overflow: excess production (light chains in myeloma, myoglobin)
Hematuria
Definitions:
- Gross hematuria: visible blood
- Microscopic: >3 RBCs/hpf on two separate urinalyses
Localization by urine RBC morphology:
- Dysmorphic RBCs + RBC casts = GLOMERULAR origin (acanthocytes = pathognomonic)
- Normal-shaped RBCs = urological origin (stone, tumor, infection, trauma)
Causes by age/sex:
- Young adult: IgA nephropathy (post-exercise gross hematuria), thin basement membrane disease
- Middle-aged woman: UTI, bladder tumor
- Older man: prostate disease, bladder cancer
"Painless gross hematuria in smoker = bladder cancer until proven otherwise"
Casts
| Cast Type | What It Means |
|---|
| RBC casts | Glomerulonephritis (nephritis) |
| WBC casts | Pyelonephritis, AIN |
| Granular (muddy brown) casts | ATN |
| Hyaline casts | Normal (concentrated urine) or pre-renal |
| Waxy/broad casts | Advanced CKD (low flow through dilated tubules) |
| Fatty casts / oval fat bodies | Nephrotic syndrome (lipiduria) |
| Tubular epithelial cell casts | ATN |
Memory: "Red cells = Renal glomerular; White cells = infection/interstitial; Muddy brown = ATN; Waxy = CKD"
CHAPTER 55 - INTERSTITIAL CYSTITIS / BLADDER PAIN SYNDROME (IC/BPS)
The Big Picture
IC/BPS is chronic bladder pain without infection. It is underdiagnosed, predominantly affects women, and is a diagnosis of exclusion. The pathophysiology involves defective urothelial barrier function.
Definition and Epidemiology
IC/BPS: Unpleasant sensation (pain, pressure, discomfort) perceived to be related to the urinary bladder, associated with lower urinary tract symptoms for >6 weeks, in the absence of infection or other identifiable causes
Demographics:
- Predominantly affects women (female:male ~5:1)
- Peak age: 40-60 years
- Prevalence: 2-7% of women
Pathophysiology - 3 Key Mechanisms
-
Defective glycosaminoglycan (GAG) layer of urothelium - normally protects bladder wall from urine irritants; when defective, urine constituents (especially potassium) penetrate into submucosa and trigger inflammation
-
Neurogenic inflammation - activation of bladder mast cells → release of histamine, prostaglandins, substance P → suburothelial inflammation
-
Central sensitization - chronic pain processing in CNS leads to allodynia and hyperalgesia beyond the bladder (overlap with IBS, fibromyalgia, vulvodynia)
🎯 Clinical Features - The Hallmark Triad
- Pelvic/suprapubic pain - worse with bladder filling, relieved by voiding
- Urinary urgency and frequency (often 8-60 voids/day)
- Nocturia
Associated features: dyspareunia (pain with sex), perineal/testicular pain in men, symptoms worsened by coffee, alcohol, acidic foods, stress
Hunner Lesions: Reddish patches/ulcers on bladder wall seen at cystoscopy - present in ~5-10% (classic IC = Hunner type); associated with more severe disease
Diagnosis
IC/BPS is a diagnosis of exclusion - rule out:
- UTI (urine culture negative)
- Bladder cancer (cystoscopy + biopsy if hematuria or risk factors)
- STIs
- Endometriosis
- Overactive bladder
Investigations:
- Urinalysis + culture (must be negative)
- Potassium sensitivity test (Parson's test): Intravesical instillation of KCl solution - positive (pain) supports IC/BPS but not widely used now
- Cystoscopy + hydrodistension (under anesthesia): reveals petechiae ("glomerulations") after distension - supportive but not pathognomonic
- Bladder biopsy: Rules out carcinoma in situ; may show mast cell infiltration
Treatment - Stepwise
| Step | Treatment |
|---|
| 1st line | Education, dietary modification (avoid caffeine, alcohol, acid foods, artificial sweeteners), stress reduction, bladder training |
| 2nd line | Oral: amitriptyline (TCA), hydroxyzine (antihistamine), PPS (pentosan polysulfate - restores GAG layer); Physical therapy (pelvic floor) |
| 3rd line | Intravesical: DMSO (dimethyl sulfoxide), heparin, lidocaine, alkalinized lidocaine; cystoscopy with hydrodistension |
| 4th line | Cyclosporine A, neuromodulation (sacral nerve stimulation) |
| 5th line | Botulinum toxin (Botox) intravesical injection |
| Last resort | Major surgery (cystectomy + urinary diversion) - only for severe refractory Hunner IC |
Memory for treatment: "EAT PAIN" - Education, Amitriptyline, Training (bladder), PPS, Antihistamines, Intravesical, Neuromodulation
CHAPTER 56 - FLUID AND ELECTROLYTE DISTURBANCES
The Big Picture
This is the highest-yield chapter in all of internal medicine. Master sodium (volume/osmolality) and potassium separately - they regulate different things. Sodium governs water distribution (osmolality); potassium governs resting membrane potential and cardiac rhythm.
SODIUM DISORDERS
Normal Physiology
- Normal serum Na+: 136-145 mEq/L
- Sodium is the major extracellular osmole - it determines plasma osmolality
- Plasma osmolality = 2[Na+] + Glucose/18 + BUN/2.8 (normal ~285-295 mOsm/kg)
- ADH (vasopressin) controls water reabsorption in collecting duct
- High osmolality → ADH secretion → water retained → dilutes Na+ back to normal
HYPONATREMIA (Na+ < 136 mEq/L)
Step 1: Assess Plasma Osmolality
| Osmolality | Type | Cause |
|---|
| High (>295) | Hypertonic hyponatremia | Hyperglycemia, mannitol, sorbitol (Na+ diluted by osmotically active solute) |
| Normal (285-295) | Isotonic (pseudohyponatremia) | Hyperlipidemia, hyperproteinemia (lab artifact - measured Na+ falsely low) |
| Low (<285) | Hypotonic hyponatremia | True hyponatremia - this is the clinically relevant category |
Correction for hyperglycemia: For every 100 mg/dL rise in glucose above 100, Na+ drops by ~1.6-2.4 mEq/L (corrected Na+ = measured Na+ + 1.6 × [(glucose - 100)/100])
Step 2: Assess Volume Status (for Hypotonic Hyponatremia)
HYPOVOLEMIC (total body Na+ LOW)
Urine Na <20 = extrarenal loss (vomiting, diarrhea, sweating)
Urine Na >20 = renal loss (diuretics, Addison's, salt-wasting nephropathy)
EUVOLEMIC (total body Na+ normal, excess water)
Most common: SIADH
Also: hypothyroidism, adrenal insufficiency, psychogenic polydipsia
HYPERVOLEMIC (total body Na+ HIGH, even more water)
Urine Na <20 = heart failure, cirrhosis, nephrotic syndrome
Urine Na >20 = CKD/AKI
SIADH - The Most Tested Cause of Hyponatremia
Criteria (Schwartz-Bartter):
- Hypotonic hyponatremia (serum osmolality <275)
- Urine inappropriately concentrated (urine osmolality >100; usually >300)
- Urine Na+ >40 mEq/L (kidneys not conserving Na+ despite low plasma Na+)
- Normal volume status (no edema, no dehydration)
- Normal renal, adrenal, thyroid function
- No diuretics
Causes - "SIADH Causes" Mnemonic: "CNS PUMP D"
- CNS disorders: meningitis, SAH, stroke, head trauma, psychosis
- Neoplasms: small cell lung cancer (most common tumor cause), pancreas, lymphoma
- S - surgery (post-op)
- Pulmonary: pneumonia, TB, COPD, mechanical ventilation
- Unknown (idiopathic - elderly)
- Medications: carbamazepine, SSRIs, opioids, chlorpropamide, cyclophosphamide, oxytocin
- Pain
- Drugs (others): NSAIDs (enhance ADH action), tricyclics
Treatment of Hyponatremia - CRITICAL to Know
Rate of Correction (The Most Important Rule in Electrolytes):
Never correct Na+ faster than 8-10 mEq/L per 24 hours (max 12 mEq/L/24hr)
Why? Rapid correction in CHRONIC hyponatremia causes Osmotic Demyelination Syndrome (ODS) = central pontine myelinolysis - devastating neurological injury (dysarthria, dysphagia, paraparesis, coma)
Risk factors for ODS: alcoholism, malnutrition, hypokalemia, liver disease, women (especially premenopausal)
| Situation | Treatment |
|---|
| Asymptomatic chronic hyponatremia (SIADH) | Fluid restriction (primary); demeclocycline or tolvaptan (V2 receptor antagonist - "vaptans") |
| Symptomatic (seizures, coma) | 3% NaCl (hypertonic saline) - give enough to raise Na+ 1-2 mEq/L/hr until symptoms resolve, then slow to <8/24hr |
| Hypovolemic | Isotonic saline (NS) - restores volume, suppresses ADH |
| Heart failure/cirrhosis | Fluid restriction + treat underlying cause; tolvaptan if severe |
Vaptans (tolvaptan, conivaptan): V2 receptor antagonists - block ADH action in collecting duct → aquaresis (free water loss without Na+ loss). Used in SIADH and hypervolemic hyponatremia (HF, cirrhosis). Tolvaptan restricted use due to hepatotoxicity in cirrhosis.
HYPERNATREMIA (Na+ > 145 mEq/L)
Always means free water deficit (relative to Na+)
Causes:
- Water loss > Na+ loss:
- Renal: Diabetes insipidus (central or nephrogenic), loop diuretics, osmotic diuresis
- Extrarenal: diarrhea, sweating, fever, burns, mechanical ventilation
- Inadequate water intake: elderly, altered consciousness, intubated patients
- Na+ gain: hypertonic saline, sodium bicarbonate, hyperaldosteronism (rare)
Diabetes Insipidus (DI)
| Feature | Central DI | Nephrogenic DI |
|---|
| Defect | Insufficient ADH production | Kidney insensitive to ADH |
| Causes | Head trauma, pituitary surgery, tumor, sarcoidosis, idiopathic | Lithium (most common), hypercalcemia, hypokalemia, genetic (V2R mutation), sickle cell |
| Urine after water deprivation | Very dilute | Very dilute |
| Response to desmopressin | Urine concentrates (positive) | No response (negative) |
| Treatment | Desmopressin (DDAVP) | Treat cause; thiazides + low Na+ diet (paradoxical); NSAIDs, amiloride (for Li-induced) |
Treatment of Hypernatremia:
- Replace free water deficit
- Formula: Free water deficit = 0.6 × weight(kg) × ([Na+/140] - 1)
- Correct slowly: no faster than 10-12 mEq/L per 24 hours
- Rapid correction → cerebral edema
- Route: oral (preferred) or D5W IV; avoid isotonic saline (contains Na+)
POTASSIUM DISORDERS
Normal Physiology
- Normal serum K+: 3.5-5.0 mEq/L
- 98% of body K+ is intracellular (mainly muscle) - only 2% extracellular
- K+ shifts between compartments rapidly (acidosis → K+ out of cells; alkalosis → K+ into cells)
- Each 0.1 unit drop in pH → ~0.6 mEq/L rise in serum K+ (and vice versa)
- Kidneys control long-term K+ balance via principal cells of collecting duct (aldosterone-regulated)
HYPOKALEMIA (K+ < 3.5 mEq/L)
Causes Framework:
1. Transcellular Shift (into cells) - NO total body deficit:
- Insulin administration (drives K+ into cells via Na/K-ATPase)
- Beta-2 agonists (albuterol, ritodrine/tocolytic)
- Alkalosis
- Thyrotoxicosis (thyrotoxic periodic paralysis - especially Asian/Latin patients)
- Familial hypokalemic periodic paralysis - attacks of weakness at night/early morning
2. Inadequate Intake - rare (kidneys conserve well)
3. Increased Losses:
- GI losses: Vomiting (metabolic alkalosis + low Cl-), diarrhea, fistulas, NG drainage
- Urine K+ <20 mEq/day = GI loss
- Renal losses:
- Diuretics (most common cause overall!) - especially loop + thiazides
- Mineralocorticoid excess (Conn's syndrome, Cushing's) - aldosterone drives K+ excretion
- Renal tubular acidosis type 1 and 2
- Hypomagnesemia (blocks tubular K+ reabsorption - must correct Mg2+ to correct K+!)
- Bartter's syndrome (loop-like defect), Gitelman's syndrome (thiazide-like defect)
- Urine K+ >20 mEq/day = renal loss
Clinical Features of Hypokalemia:
| System | Manifestations |
|---|
| Cardiac | U waves (most classic), flattened/inverted T waves, prolonged QU, ventricular arrhythmias, worsens digoxin toxicity |
| Neuromuscular | Weakness (ascending), fatigue, cramps, paralysis (profound hypokalemia) |
| GI | Constipation, ileus |
| Renal | Nephrogenic DI (polyuria), metabolic alkalosis, hypokalemic nephropathy (chronic) |
ECG Memory: "Low K = Low T + U waves appear" - U wave is positive deflection after T wave, best seen V2-V3
Treatment of Hypokalemia:
- Mild (3.0-3.5): oral KCl replacement; increase dietary K+ (banana, orange, potato)
- Moderate-severe (<3.0 or symptomatic): IV KCl at maximum 10-20 mEq/hr (never faster - cardiac arrest risk)
- Always correct hypomagnesemia first - hypomagnesemia causes refractory hypokalemia
- If on diuretics: switch to K+-sparing (spironolactone, amiloride, triamterene)
HYPERKALEMIA (K+ > 5.0 mEq/L)
Causes Framework - "3 D's": Don't, Dilute, Dump
More precisely:
- Pseudohyperkalemia (lab artifact): hemolysis of blood sample, thrombocytosis, leukocytosis - repeat test
- Transcellular shift (out of cells):
- Acidosis (metabolic or respiratory) - each 0.1 pH drop → +0.6 mEq/L K+
- Insulin deficiency (DKA)
- Hyperkalemic periodic paralysis
- Beta-blocker overdose
- Tissue necrosis (rhabdomyolysis, tumor lysis, hemolysis, burns)
- Succinylcholine (depolarizing neuromuscular blocker) - causes dangerous K+ release in burn, crush, denervation patients
- Reduced renal excretion (most common true cause):
- AKI / CKD
- Hypoaldosteronism: Addison's disease, type 4 RTA (hyporeninemic hypoaldosteronism - common in diabetic nephropathy)
- Drugs: ACE inhibitors, ARBs, K+-sparing diuretics (spironolactone, amiloride), NSAIDs, trimethoprim, heparin
- Excess intake: IV potassium, blood transfusion (old stored blood), salt substitutes
Clinical Features - Cardiac Danger!
ECG Changes (progression with rising K+):
K+ 5.5-6.5: Peaked (tall, narrow, symmetric) T waves
K+ 6.5-7.5: Prolonged PR, wide QRS
K+ >7.5: Loss of P waves, sine wave pattern
K+ >8-9: Ventricular fibrillation / asystole → DEATH
Memory: "Peaked T → PR long → QRS wide → No P → Sine wave → VF"
Muscle: weakness, paralysis (with severe hyperkalemia)
Treatment of Hyperkalemia - Know the "CBDIG" Protocol:
| Drug | Mechanism | Onset | Duration | Notes |
|---|
| Calcium gluconate (10 mL 10%) | Membrane stabilization - antagonizes cardiac effects | Minutes | 30-60 min | Does NOT lower K+; first step when ECG changes present |
| Bicarbonate (NaHCO3) | Drives K+ into cells (alkalinization) | 15-30 min | Hours | Less effective in CKD; best in acidemic patients |
| Dextrose + Insulin (D50W + 10 U regular insulin) | Drives K+ into cells | 20-30 min | 4-6 hr | Most reliable intracellular shift; watch glucose |
| Inhaled beta-2 agonist (albuterol nebulized) | Drives K+ into cells | 20-30 min | 2-4 hr | Additive to insulin; 10-20 mg dose needed |
| Gastrointestinal/renal removal: | | | | |
| - Sodium polystyrene sulfonate (Kayexalate) | Ion exchange resin - removes K+ in gut | Hours | - | Risk of intestinal necrosis (caution post-op) |
| - Patiromer (Veltassa) | Newer K+ binder, better tolerated | Hours | - | Preferred over Kayexalate |
| - Sodium zirconium cyclosilicate (Lokelma) | Traps K+ in gut | Hours | - | Newer, rapid onset |
| Dialysis | Removes K+ directly | Fast | - | For severe/refractory or oliguric AKI |
The order: Calcium first (protects heart) → Shift K+ in (bicarb/insulin/beta-agonist) → Remove K+ from body (resins/dialysis)
CHAPTER 57 - HYPERCALCEMIA AND HYPOCALCEMIA
The Big Picture
Calcium balance is controlled by PTH, Vitamin D (1,25-OH2D), and calcitonin. The key to all calcium disorders is: check PTH first - it tells you whether the parathyroids are the problem or compensating for a problem elsewhere.
Normal Calcium Physiology
- Normal total calcium: 8.5-10.5 mg/dL (ionized Ca2+ = 4.6-5.1 mg/dL)
- ~50% bound to albumin, ~10% complexed (citrate, phosphate), ~40% ionized (biologically active)
- Correct for albumin: For every 1 g/dL drop in albumin below 4, add 0.8 mg/dL to measured calcium
- Calcium regulation:
- PTH: raises Ca2+ (bone resorption + renal Ca2+ reabsorption + activates Vit D)
- 1,25-(OH)2D (calcitriol): raises Ca2+ (intestinal absorption)
- Calcitonin: lowers Ca2+ (used acutely; long-term effect minimal)
- FGF-23: lowers phosphate (opposite of PTH on phosphate)
HYPERCALCEMIA (Calcium > 10.5 mg/dL)
Causes - The "CHIMPANZEES" Mnemonic
| Letter | Cause |
|---|
| C | Calcium supplementation excess |
| H | Hyperparathyroidism (primary - most common outpatient cause) |
| I | Immobilization |
| M | Milk-alkali syndrome (calcium carbonate + antacids) |
| P | Paget's disease of bone |
| A | Addison's disease |
| N | Neoplasm (most common inpatient cause!) |
| Z | Zollinger-Ellison syndrome |
| E | Excess Vitamin D |
| E | Endocrine (thyrotoxicosis, acromegaly, VIPoma) |
| S | Sarcoidosis / other granulomas (macrophages produce 1,25-OH2D ectopically) |
Two Giants: Primary Hyperparathyroidism vs. Malignancy
| Feature | Primary Hyperparathyroidism | Malignancy |
|---|
| PTH | Elevated | Suppressed |
| Onset | Chronic, often asymptomatic | Acute, often severe |
| PTHrP | Normal | Often elevated (HHM - humoral hypercalcemia of malignancy) |
| Serum Cl-:PO4 ratio | >33 | <30 |
| ALP | Mildly elevated | May be elevated (bony mets) |
| Setting | Outpatient, incidental finding | Known cancer or acute illness |
Mechanisms of malignancy-associated hypercalcemia:
- Humoral (most common ~80%): PTHrP secretion (squamous cell lung, breast, renal, bladder)
- Osteolytic metastases: Myeloma, breast cancer - local bone destruction
- Ectopic 1,25-D production: Lymphomas (like sarcoid mechanism)
- Ectopic PTH: Extremely rare
Clinical Features of Hypercalcemia - "Bones, Stones, Groans, Psychic Moans, Thrones"
| Domain | Features |
|---|
| Bones | Bone pain, pathological fractures, subperiosteal resorption (hyperparathyroidism - radial side of index finger), osteitis fibrosa cystica, "salt and pepper skull" |
| Stones | Nephrolithiasis (calcium oxalate >> calcium phosphate), nephrocalcinosis, polyuria/polydipsia (nephrogenic DI) |
| Groans | Nausea, vomiting, constipation, pancreatitis, peptic ulcers |
| Psychic Moans | Depression, anxiety, cognitive impairment, psychosis |
| Thrones | Polyuria, dehydration (nephrogenic DI effect) |
Cardiac: Shortened QTc interval, bradycardia, AV block (severe)
Treatment of Hypercalcemia
Acute Severe Hypercalcemia (Ca2+ > 14 mg/dL or symptomatic):
| Step | Treatment | Mechanism |
|---|
| 1. | IV Normal Saline (1-2 L/hr) | Volume expansion → promotes renal Ca2+ excretion; first and most important step |
| 2. | Loop diuretics (furosemide) after adequate hydration | Inhibit Ca2+ reabsorption in TAL |
| 3. | IV Bisphosphonates (zoledronic acid or pamidronate) | Inhibit osteoclast activity - takes 2-4 days to work but sustained effect |
| 4. | Calcitonin (salmon calcitonin SC/IM) | Rapid onset (hours); inhibits osteoclasts + increases renal Ca excretion; tachyphylaxis in 48-72 hrs (use to bridge while bisphosphonate kicks in) |
| 5. | Denosumab | Anti-RANKL; for refractory/bisphosphonate-resistant hypercalcemia |
| 6. | Glucocorticoids | For sarcoidosis/lymphoma/Vit D toxicity (inhibit 1,25-D production) |
| 7. | Dialysis | For severe/refractory or renal failure |
Memory: "Saline First - then add Furosemide - then Bisphosphonate - then Calcitonin (quick bridge)"
Primary Hyperparathyroidism:
- Symptomatic (stones, fractures, neurocognitive): Parathyroidectomy (curative)
- Asymptomatic indications for surgery: Ca2+ >1 mg/dL above ULN, T-score <-2.5 at any site, age <50, 24-hr urine Ca >400 mg, CrCl <60 mL/min
- Medical management if not surgical candidate: Cinacalcet (calcimimetic - activates calcium-sensing receptor → suppresses PTH)
HYPOCALCEMIA (Calcium < 8.5 mg/dL)
Causes Framework - "PTH? Then Vitamin D? Then Other?"
PTH deficient (Hypoparathyroidism):
- Post-surgical (most common): thyroidectomy, parathyroidectomy, radical neck dissection
- Autoimmune: DiGeorge syndrome (22q11 deletion), autoimmune polyglandular syndrome type 1
- Hypomagnesemia (<1.2 mg/dL): blocks PTH secretion AND causes PTH resistance - must correct Mg2+ first!
- Radiation, infiltrative (hemochromatosis, Wilson's, malignancy)
PTH resistant (Pseudohypoparathyroidism):
- PTH high but kidneys don't respond (Gs protein defect)
- Type 1a: "Albright's hereditary osteodystrophy" - short stature, round face, short 4th metacarpal, subcutaneous calcifications
Vitamin D disorders:
- Nutritional deficiency (most common worldwide)
- Malabsorption (Crohn's, celiac, bariatric surgery)
- CKD: impaired 1α-hydroxylase → cannot activate Vit D
- Vitamin D resistance (type II rickets)
Other causes:
- Hyperphosphatemia (binds Ca2+ → precipitates): AKI, rhabdomyolysis, tumor lysis, excess phosphate
- Pancreatitis (fat saponification consumes Ca2+)
- Alkalosis (increases albumin binding of Ca2+ → reduces ionized Ca2+)
- Osteoblastic metastases (prostate, breast cancer): Ca2+ deposited into bone
- Hungry bone syndrome (after parathyroidectomy - bones avidly take up Ca2+)
Clinical Features of Hypocalcemia - Neuromuscular Excitability
"CATS go numb":
- Convulsions
- Arrhythmias (prolonged QTc → Torsades de pointes)
- Tetany (carpopedal spasm, laryngospasm, bronchospasm)
- Spasms and stridor
Signs:
- Chvostek's sign: Tap facial nerve (anterior to ear) → ipsilateral facial twitch (present in ~10% of normal - low specificity)
- Trousseau's sign: BP cuff inflated 20 mmHg above systolic for 3 min → carpal spasm (thumb adduction + wrist flexion) - more specific than Chvostek's
Chronic hypocalcemia:
- Cataracts (subcapsular)
- Calcification of basal ganglia (parkinsonism, choreoathetosis)
- Dental enamel hypoplasia
- Papilledema (pseudotumor cerebri)
- Prolonged QTc on ECG
Treatment of Hypocalcemia
Acute (Symptomatic - Tetany/Seizures):
- IV Calcium gluconate (10-20 mL of 10% = 90-180 mg elemental Ca2+) over 10-20 minutes
- Followed by calcium infusion (calcium gluconate in D5W)
- Caution: IV calcium precipitates with bicarbonate/phosphate - use separate lines
Chronic (Hypoparathyroidism):
- Oral calcium carbonate (with food - acid needed for absorption) OR calcium citrate (without food)
- Active vitamin D: Calcitriol (1,25-OH2D) - bypass need for renal activation; start 0.25 mcg BID
- Target Ca2+ at low-normal (8-8.5 mg/dL) to avoid hypercalciuria + nephrolithiasis
- Recombinant PTH (Natpara/palopegteriparatide) for refractory hypoparathyroidism
CHAPTER 58 - ACIDOSIS AND ALKALOSIS
The Big Picture
Acid-base disorders are best approached with a systematic 5-step method. Never skip steps. The Henderson-Hasselbalch relationship and compensation rules are mathematical facts - learn them once, apply them forever.
Foundation: The pH Equation
Henderson-Hasselbalch: pH = 6.1 + log([HCO3-] / (0.03 × PaCO2))
Normal values:
- pH: 7.35-7.45
- PaCO2: 35-45 mmHg
- HCO3-: 22-26 mEq/L
Simplified Henderson equation: [H+] (in nEq/L) = 24 × PaCO2 / HCO3-
🎯 The 5-Step Systematic Approach (Use Every Time)
Step 1: Is pH acidemic or alkalemic?
- pH <7.35 = Acidemia
- pH >7.45 = Alkalemia
Step 2: Is the primary disorder respiratory or metabolic?
- Metabolic acidosis: pH ↓ + HCO3- ↓
- Metabolic alkalosis: pH ↑ + HCO3- ↑
- Respiratory acidosis: pH ↓ + PaCO2 ↑
- Respiratory alkalosis: pH ↑ + PaCO2 ↓
Step 3: Is compensation appropriate?
(If not, a second disorder is also present)
| Primary Disorder | Expected Compensation |
|---|
| Metabolic acidosis | PaCO2 = 1.5 × HCO3- + 8 ± 2 (Winter's formula) |
| Metabolic alkalosis | PaCO2 increases ~0.7 mmHg per 1 mEq/L rise in HCO3- (max ~55) |
| Respiratory acidosis (acute) | HCO3- rises 1 mEq/L per 10 mmHg rise in PaCO2 |
| Respiratory acidosis (chronic) | HCO3- rises 3.5 mEq/L per 10 mmHg rise in PaCO2 |
| Respiratory alkalosis (acute) | HCO3- falls 2 mEq/L per 10 mmHg fall in PaCO2 |
| Respiratory alkalosis (chronic) | HCO3- falls 5 mEq/L per 10 mmHg fall in PaCO2 |
Chronic compensation is always greater than acute - the kidney has had time to respond
Step 4: Calculate Anion Gap (if metabolic acidosis present)
AG = Na+ - (Cl- + HCO3-) Normal = 8-12 mEq/L (some labs 3-11 if different normal albumin)
Correct for hypoalbuminemia: Corrected AG = Measured AG + 2.5 × (4.0 - albumin in g/dL)
Step 5: If high AG acidosis, calculate Delta-Delta ratio
Delta-Delta (Δ/Δ) = (AG - 12) / (24 - HCO3-)
| Δ/Δ Ratio | Interpretation |
|---|
| <0.4 | Pure non-AG (hyperchloremic) acidosis |
| 0.4-1.0 | Mixed high AG + non-AG acidosis |
| 1.0-2.0 | Pure high AG metabolic acidosis |
| >2.0 | High AG acidosis + concurrent metabolic alkalosis (pre-existing elevated HCO3-) |
METABOLIC ACIDOSIS
High Anion Gap (AG > 12) - "MUDPILES / GOLDMARK"
MUDPILES:
- Methanol
- Uremia (AKI/CKD)
- Diabetic ketoacidosis (most common)
- Propylene glycol (IV lorazepam, other drugs)
- Isoniazid / Iron toxicity
- Lactic acidosis
- Ethylene glycol
- Salicylates
GOLDMARK (more complete modern version):
- Glycols (ethylene glycol, propylene glycol)
- Oxoproline (acetaminophen toxicity - chronic, often missed)
- Lactic acidosis
- D-lactic acidosis (short bowel)
- Methanol
- Aspirin (salicylates)
- Renal failure (uremia)
- Ketoacidosis (DKA, alcoholic, starvation)
Lactic Acidosis (Most Important High AG Cause in Hospital)
Type A: Tissue hypoperfusion / hypoxia
- Sepsis, cardiogenic shock, mesenteric ischemia, severe anemia, CO poisoning
Type B: No tissue hypoxia, mitochondrial/metabolic
- Metformin (especially in AKI), liver failure, thiamine deficiency, HIV drugs (NRTIs), malignancy, alcohol, cyanide
Key point: Metformin must be held when GFR <30 - accumulates and causes type B lactic acidosis
Normal Anion Gap (Hyperchloremic) Metabolic Acidosis
Causes: "HARDUPS"
- Hyperalimentation (TPN)
- Addison's disease (hypoaldosteronism)
- RTA (renal tubular acidosis)
- Diarrhea (loss of HCO3- in stool - most common cause worldwide)
- Ureteral diversion (uretero-sigmoidostomy)
- Pancreatic fistula
- Saline infusion excess (dilutional)
Renal Tubular Acidosis (RTA) - High Yield Table
| Type | Defect | Serum K+ | Urine pH | Causes | Treat |
|---|
| Type 1 (distal) | Cannot acidify urine in distal tubule | Low (hypokalemia) | >5.5 | Sjögren's, SLE, amphotericin B, medullary sponge kidney | Oral bicarb + K+ |
| Type 2 (proximal) | Cannot reabsorb HCO3- | Low (hypokalemia) | <5.5 (can acidify) | Fanconi syndrome (myeloma, Wilson's, tenofovir, ifosfamide) | Large doses bicarb; K+ |
| Type 4 | Hypoaldosteronism / aldosterone resistance | High (hyperkalemia) | <5.5 | Diabetic nephropathy, ACE inhibitors, heparin, Addison's | Fludrocortisone or treat cause; kayexalate |
Type 3 RTA is obsolete/rarely used.
Memory: "Type 1 = distal = can't drop pH (>5.5) = stones + nephrocalcinosis"
Treatment of Metabolic Acidosis:
- Treat underlying cause (primary goal)
- NaHCO3 for severe acidosis (pH <7.1 or HCO3- <10): formula: Bicarb deficit = 0.5 × weight × (desired HCO3- - actual HCO3-)
- DKA: Insulin + IV fluids + K+ replacement (not bicarb unless pH <6.9)
- Lactic acidosis: Treat cause; bicarb controversial (may worsen intracellular acidosis, increases CO2)
METABOLIC ALKALOSIS
The Big Picture
Metabolic alkalosis = elevated HCO3-. Requires two things: (1) generation (gain of HCO3- or loss of acid), (2) maintenance (kidneys fail to excrete excess HCO3-, usually due to volume/chloride/K+ depletion)
Causes:
Chloride-Responsive (Urine Cl- < 20 mEq/L) - "SALINE responsive":
- Vomiting / NG suction (most common): lose HCl → bicarb generation; volume contraction → aldosterone → more H+ excretion
- Loop or thiazide diuretics (once stopped): volume contraction + K+ loss
- Post-hypercapnia: Chronic CO2 retention → renal HCO3- retention; if respiratory problem corrected rapidly, HCO3- remains
Chloride-Resistant (Urine Cl- > 20 mEq/L) - "SALINE resistant":
- Mineralocorticoid excess: Primary aldosteronism (Conn's), Cushing's, licorice (glycyrrhizin acts like mineralocorticoid), Liddle's syndrome
- Severe hypokalemia (K+ shift out of cells → H+ shifts in → bicarb generation)
- Bartter's syndrome / Gitelman's syndrome (hereditary tubular disorders)
Urine Cl- is the key test (not urine Na+ - misleading because large bicarb is being excreted, pulling Na+ with it)
Clinical Features:
- Often asymptomatic if mild
- Reduced ionized calcium → paresthesias, cramps, Chvostek's/Trousseau's signs (same as hypocalcemia)
- Hypoventilation (compensation - PaCO2 rises)
- Hypokalemia (often coexists)
- Cardiac arrhythmias
Treatment:
| Type | Treatment |
|---|
| Chloride-responsive (vomiting, diuretics) | IV Normal Saline (NaCl) + KCl replacement; correct volume/Cl- deficit; this allows kidneys to excrete excess HCO3- |
| Mineralocorticoid excess | Treat underlying cause; spironolactone; surgery (adenoma) |
| Severe/refractory | Acetazolamide (carbonic anhydrase inhibitor → forces HCO3- excretion); HCl infusion (rare) |
RESPIRATORY ACIDOSIS
Mechanism: Hypoventilation → CO2 retention → carbonic acid accumulates → pH falls
Causes - "CNS → Nerve → Muscle → Lung → Airway"
| Level | Examples |
|---|
| CNS depression | Opioids (most common!), sedatives, benzodiazepines, stroke, brainstem lesion |
| Nerve/motor neuron | ALS, GBS, phrenic nerve palsy, C3-4-5 cord injury |
| Neuromuscular junction | Myasthenia gravis, Lambert-Eaton, botulism, organophosphate |
| Respiratory muscles | Muscular dystrophy, polymyositis, severe hypokalemia/hypophosphatemia |
| Lungs | COPD (chronic), severe pneumonia, ARDS, pulmonary edema |
| Airway | Foreign body, laryngospasm, obstructive sleep apnea |
Acute vs. Chronic:
- Acute: rapid rise in CO2, HCO3- barely rises (non-renal buffering), pH drops severely
- Chronic: kidneys retain HCO3- over days, pH partially corrected
Treatment: Improve ventilation (treat cause, supplemental O2, NIV, intubation if necessary)
Caution: In COPD "CO2 retainers," DO NOT give high-flow O2 blindly - eliminates hypoxic drive → worsening CO2 retention; use controlled O2 to target SpO2 88-92%
RESPIRATORY ALKALOSIS
Mechanism: Hyperventilation → excess CO2 blown off → pH rises
Causes - "HAMPER"
- Hypoxia (PE, pneumonia, high altitude, severe anemia) - most important
- Anxiety / pain (psychogenic hyperventilation)
- Mechanical ventilation (iatrogenic over-ventilation)
- Pregnancy (progesterone stimulates respiratory center)
- Encephalopathy (hepatic, sepsis, CNS disease)
- Respiratory stimulants (salicylates - early; fever; sepsis)
Clinical Features: Dizziness, light-headedness, perioral numbness, carpopedal spasm (↓ ionized Ca2+), acral tingling
Treatment: Treat underlying cause; for anxiety/psychogenic: breathe into bag (increases inspired CO2); benzodiazepines
🔗 Mixed Acid-Base Disorders - Common Clinical Combinations
| Combination | Clinical Setting |
|---|
| Metabolic acidosis + Respiratory alkalosis | Salicylate poisoning (early), sepsis, liver failure |
| Metabolic alkalosis + Respiratory acidosis | COPD + vomiting/diuretics |
| Metabolic acidosis + Metabolic alkalosis | Uremia + vomiting (high AG + high HCO3-: Δ/Δ >2.0) |
| Respiratory acidosis + Metabolic alkalosis | Mechanical ventilation partially correcting COPD retainer |
| Metabolic acidosis + Respiratory acidosis | Cardiorespiratory arrest (severe!) |
📋 RAPID REVIEW - ONE-LINERS FOR CHAPTERS 54-58
- FENa <1% = pre-renal; >2% = ATN (use FEUrea if on diuretics)
- Muddy brown granular casts = ATN (most common cause of AKI in hospital)
- RBC casts = glomerulonephritis; WBC casts = pyelonephritis or AIN
- IC/BPS = bladder pain + frequency + negative culture - diagnosis of exclusion
- Trousseau's sign is MORE specific for hypocalcemia than Chvostek's
- SIADH: urine Na+ >40 + urine osm >100 + euvolemia - concentrated urine inappropriately
- Correct Na+ no faster than 8-10 mEq/L/24 hr - risk of ODS/central pontine myelinolysis
- Central DI: concentrates with desmopressin; Nephrogenic DI: does not
- Lithium = most common cause of nephrogenic DI (drug-induced)
- Hypokalemia ECG = U waves (best seen V2-V3); Hyperkalemia = peaked T waves first
- Always correct hypomagnesemia before correcting hypokalemia - refractory otherwise
- Calcium gluconate is the FIRST treatment for hyperkalemia ECG changes (membrane stabilization)
- Primary hyperPTH = high PTH + hypercalcemia; Malignancy = suppressed PTH + high Ca2+
- "Bones, Stones, Groans, Psychic Moans, Thrones" = hypercalcemia symptoms
- Calcitonin works fast (hours) but tachyphylaxis in 48-72 hrs - use as bridge to bisphosphonate
- Winter's formula: expected PaCO2 = 1.5 × HCO3- + 8 ± 2 (metabolic acidosis compensation)
- DKA = high AG metabolic acidosis (most common cause in clinical practice)
- Urine Cl- <20 = saline-responsive alkalosis (vomiting, diuretics); >20 = saline-resistant (hyperaldosteronism)
- Type 4 RTA = hyperkalemia + normal AG acidosis = diabetic nephropathy
- "Pain out of proportion + metabolic acidosis" = mesenteric ischemia / lactic acidosis
🔗 CROSS-CHAPTER CONNECTIONS
| Scenario | Chapters | Diagnosis |
|---|
| Oliguria + FENa <1% + BUN:Cr >20 | 54 | Pre-renal AKI |
| Bladder pain + negative culture + urgency | 55 | IC/BPS |
| Hyponatremia + concentrated urine + euvolemia | 56 | SIADH |
| Hyponatremia + rapid correction + paraplegia | 56 | Osmotic demyelination syndrome |
| Hyperkalemia + peaked T waves + ACE inhibitor | 56 | Drug-induced hyperkalemia |
| Hypercalcemia + suppressed PTH + lung mass | 57 | Humoral hypercalcemia of malignancy |
| Hypocalcemia + post-thyroidectomy + tetany | 57 | Surgical hypoparathyroidism |
| High AG acidosis + elevated lactate + sepsis | 58 | Type A lactic acidosis |
| Normal AG acidosis + hypokalemia + urine pH >5.5 | 58 | Distal RTA (Type 1) |
| Metabolic alkalosis + low urine Cl- + vomiting history | 58 | Contraction alkalosis - saline responsive |
Source: Harrison's Principles of Internal Medicine, 22nd Edition (2025, McGraw Hill Medical) - Section 7, Chapters 54-58
This guide covers every high-yield concept from all five chapters. The bolded rules and one-liners at the end are your rapid-review layer. Study the cross-chapter connections last - those are the cases examiners write and real patients present. Master the frameworks (the 5-step acid-base approach, the azotemia classification, the Ca2+ PTH decision tree) and you will be able to handle any question or patient confidently.